Shangqin Liu
Overview
Explore the profile of Shangqin Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song Z, Cui Y, Xin L, Xiao R, Feng J, Li C, et al.
Cell Stem Cell
. 2025 Feb;
PMID: 39986274
Mitochondria are integrated within the cytoskeleton for structural integrity and functional regulation, yet the pathological exploitation of these interactions in cell fate decisions remains largely unexplored. Here, we identify a...
2.
Wu T, Liu D, Liu S, Xiao H, Xiong B, Zhou Y, et al.
Ren Fail
. 2024 May;
46(1):2356708.
PMID: 38803220
As no unified treatment protocol or evidence yet exists for plasmapheresis without plasma, this study explored the outcomes of using 4% human albumin (ALB) solution as a replacement solution in...
3.
4.
Maskey N, Chen Q, Liu F, Liu S, Tian S
Diagn Pathol
. 2020 Apr;
15(1):31.
PMID: 32245492
Background: Reverse Variant of Follicular Lymphoma (RVFL) is one of the rare morphological variants of FL, characterized by dark staining small centrocytes in the center and pale staining large centroblasts...
5.
Yan H, Sun Y, Wu Q, Wu Z, Hu M, Sun Y, et al.
Front Oncol
. 2020 Mar;
9:1423.
PMID: 32117782
Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1), a co-activator of estrogen receptors alpha, was confirmed to be directly associated with the oncogenic process of multiple cancers, especially hormone-dependent cancers....
6.
Maskey N, Thapa N, Maharjan M, Shrestha G, Maharjan N, Cai H, et al.
Cancer Manag Res
. 2019 Oct;
11:7647-7655.
PMID: 31616181
Purpose: Tumor infiltrating lymphocytes (TILs) have been extensively described in anti-tumor immunity, but their functional alterations in the immunoediting processes during neoplastic progression in the uterine cervix are still not...
7.
Jin Y, Guo S, Cui Q, Chen S, Liu X, Wei Y, et al.
Sci Rep
. 2018 Jan;
8(1):294.
PMID: 29321527
Therapeutic leukapheresis is a rapid and effective method to reduce early mortality of patients with hyperleukocytic leukaemia (HLL). However, few studies on factors influencing the efficiency have been reported. In...
8.
Liu X, Chen J, He Y, Meng X, Li K, He C, et al.
Onco Targets Ther
. 2017 Jan;
10:121-128.
PMID: 28053546
Objective: The aim of this study was to evaluate the efficacy and clinical outcome of initial therapies for elderly patients with multiple myeloma (MM). Methods: Randomized controlled trials (RCTs) were...
9.
Liu X, Liu S, Chen J, He L, Meng X, Liu S
Ann Hematol
. 2016 Aug;
95(11):1787-93.
PMID: 27506924
Although the response rates of chemotherapy in patients with acute T-lymphoblastic leukemia (T-ALL) have improved significantly, the outcome of these patients is still poor. Previous studies suggested that baicalein could...
10.
Cheng L, Zhou Q, Wang Y, Liu S
Zhonghua Xue Ye Xue Za Zhi
. 2016 Apr;
37(4):352.
PMID: 27094005
No abstract available.